Dr. Sezer - The Bone Resorption Marker Serum-ICTP and the Circulating Proteasome Levels Separate ISS-Stages 1-3 and Are the Most Powerful Prognostic Factors for Overall Survival in Newly Diagnosed Symptomatic Multiple Myeloma
Orhan Sezer, MD Medizinische Klinik und Poliklinik II Berlin, Germany Member, IMF Board of Scientific Advisors
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.